Flare Therapeutics

United States
Primghar, Iowa, United States, 02142

Company profile

Flare Therapeutics company profile

Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets for transcription factor regulation to address mutations that cause disease. Its drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.

Business identity

Contact email
[email protected]
Phone number
(857) 706-4400
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
02142
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$205M
Last funding
Series B / $123M / 2023-03-22
Last equity funding
Series B / $123M
Investors
14
Lead investors
3
Founders
4
Articles
46

Founders and investors

Founders

Fraydoon RastinejadMitchell LazarRobert SimsSteven McKnight

Lead investors

GordonMD Global InvestmentsPfizer Venture InvestmentsThird Rock Ventures

Investors

Casdin CapitalEli LillyInvusNovartisThird Rock Ventures